Skip to content
2000
Volume 13, Issue 1
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

Aβ exerts prooxidant or antioxidant effects based on the metal ion concentrations that it sequesters from the cytosol; at low metal ion concentrations, it is an antioxidant, whereas at relatively higher concentration it is a prooxidant. Thus Alzheimer disease (AD) treatment strategies based solely on the amyloid-β clearance should be re-examined in light of the vast accumulating evidence that increased oxidative stress in the human brains is the key causative factor for AD. Accumulating evidence indicates that the reduced brain glucose availability and brain hypoxia, due to the relatively lower concentration of ATP and 2,3-diphosphoglycerate, may be associated with increased concentration of endogenous ammonia, a potential neurotoxin in the AD brains. In this review, we summarize the progress in this area, and present some of our ongoing research activities with regard to brain Amyloid-β, systemic ammonia, erythrocyte energy metabolism and the role of 2,3-diphosphoglycerate in AD pathogenesis.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/18715273113126660130
2014-02-01
2025-10-04
Loading full text...

Full text loading...

/content/journals/cnsnddt/10.2174/18715273113126660130
Loading

  • Article Type:
    Research Article
Keyword(s): Alzheimer disease; ammonia; amyloid-β; erythrocyte energy metabolism; oxidative stress
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test